Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing

The company has launched a generic product in the market after having received approval from the US and Drug Administration (U.S.FDA) earlier.

The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray

According to a senior police officer, a total of 66,246 police personnel have got the first dose of coronavirus vaccine till 7 pm on Friday

Providing a final clearance for the vaccine a day after it was authorized by U.S. regulators, the Advisory Committee on Immunization Practices (ACIP) voted 12-0 to recommend the vaccine from J&J as appropriate for Americans 18 and older

Once approved, the product can be marketed in the 27 European Union (EU) member countries and European Economic Area (EEA) member states of Norway, Iceland and Liechtenstein

SS Innovations is planning to make 100 units this year of the multi arm novel 'Mantra' Surgical Robotic System indigenously developed over the last three years. Plans are to make and sell over 1,000 units within the next five years

To reach that target from the current $42 billion, the Indian pharmaceutical industry will require to double the last decade's growth rate of 6% to 12%

Patanjali's Coronil not to be sold in Maharashtra without 'proper certifications' The sale of Patanjali's Coronil tablets will not be permitted without \"proper certifications\" in Maharashtra, said the state's Home Minister Anil Deshmukh on Tuesday. Deshmukh's statements come a day after the Indian Medical Association (IMA) expressed shock over Patanjali's claims of getting WHO certification for Coronil tablets, which it says is an evidence-based medicine to fight COVID-19. Uttarakhand f...

Stock Market Updates Today: Sectorally, except for IT and pharma index, all the other indices ended with decent gains. Private, PSU Bank and financial indices closed 3% higher today.

Stocks to watch today on February 24: Coal India, Pfizer, SBI Cards, Tata Power, NTPC, UPL among others are the top stocks to watch out for in Wednesday's trading session

Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week

In the early days of COVID-19 outbreak last year, India relied on imports from leading medical companies like Roche Diagnostic, Korea's S.D Biosensor, Siemens Healthcare, Thermofisher, Abbott Healthcare, apart from Chinese and South Korean manufacturers

The programme, which the WHO said was the first and only vaccine injury compensation mechanism operating on an international scale, will offer eligible people \"a fast, fair, robust and transparent process\", the WHO said in a statement

In a tweet, the WHO South-East Asia wrote, 'WHO has not reviewed or certified the effectiveness of any traditional medicine for the treatment of COVID-19'

Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report

The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE

Stock Market News Updates Today: Bajaj Finserv, IndusInd Bank, RIL, Kotak Bank were among the top gainers today, while NTPC, PowerGrid, Asian Paints, ICICI Bank, Tata Motors were among the top losers

Bharat Biotech is in the process of filing regulatory documents for approval of its vaccine, Covaxin, in more than 40 countries

Coronavirus in India: The new facility will have a capacity to manufacture up to 10 million tests every month. CoviPath COVID-19 RT-PCR Kit has been approved by the ICMR and DCGI